Testing effectiveness (Phase 2)WithdrawnNCT03202147
What this trial is testing
Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)
Who this might be right for
Ischemic StrokePost-stroke Cognitive Impairment
AZTherapies, Inc.